BioCryst Pharmaceuticals, Inc. (BCRX)

7.70 +0.17 (+2.26%) USD  |  NASDAQ  |  Dec 24, 16:00
More

BioCryst Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for BCRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Astria Therapeutics, Inc. Upgrade
Hologic, Inc. Upgrade
Johnson & Johnson Upgrade
Viatris, Inc. Upgrade
KalVista Pharmaceuticals, Inc. Upgrade